You are here

  • Home
  • Archive
  • Volume 70, Issue 2
  • Fcγ receptor IIIb polymorphism and use of glucocorticoids at baseline are associated with infusion reactions to infliximab in patients with rheumatoid arthritis

Article info

Article menu
Clinical and epidemiological research
Concise report
Fcγ receptor IIIb polymorphism and use of glucocorticoids at baseline are associated with infusion reactions to infliximab in patients with rheumatoid arthritis

Authors

  1. Correspondence to Professor Tsutomu Takeuchi, 35 Shinanomachi, Shinjuku-ku, Tokyo 160–8582, Japan; tsutake{at}z5.keio.jp
View Full Text

Citation

Okuyama A, Nagasawa H, Suzuki K, et al
Fcγ receptor IIIb polymorphism and use of glucocorticoids at baseline are associated with infusion reactions to infliximab in patients with rheumatoid arthritis
Annals of the Rheumatic Diseases 2011;70:299-304.

Publication history

  • Accepted August 29, 2010
  • First published October 27, 2010.
Online issue publication 
October 25, 2017

  • Web Only Data

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This paper is freely available online under the BMJ Journals unlocked scheme, see http://ard.bmj.com/info/unlocked.dtl